|
⚲
|
| Keyboard |
| Chu Yu-Waye
✚
|
|
|---|---|
| CIK # | 0001854586 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001854586] | |
| 4 | [0001854586] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Chu Yu-Waye | |
| CytomX Therapeutics Inc | |
| Fate Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2026-03-17 | Sell | 21,279 | $6.42 | 136,611 |
|
CytomX Therapeutics Inc CTMX
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 300,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2026-02-02 | Grant | 75,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2025-03-18 | Sell | 4,025 | $0.60 | 2,415 |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2025-02-04 | Grant | 56,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Stock Option (Right to Buy) · derivative
|
2025-02-04 | Grant | 115,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Stock Option (Right to Buy) · derivative
|
2025-02-04 | Grant | 238,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2025-02-04 | Grant | 57,500 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Common Stock
|
2024-01-18 | Grant | 26,250 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Stock Option (Right to Buy) · derivative
|
2024-01-18 | Grant | 122,500 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Performance Stock Units (PSUs) · derivative
|
2024-01-18 | Grant | 75,000 | $0.00 | |
|
CytomX Therapeutics Inc CTMX
Stock Option (Right to Buy) · derivative
|
2023-07-19 | Grant | 375,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2023-04-18 | Sell | 2,317 | $6.58 | 15,246 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2023-04-18 | Sell | 215 | $6.52 | 1,402 |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2023-02-06 | Grant | 425,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2023-01-10 | Sell | 7,825 | $5.24 | 41,003 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-04-19 | Sell | 4,062 | $35.37 | 143,673 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-01-25 | Grant | 33,302 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2022-01-25 | Grant | 53,058 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-01-11 | Sell | 3,547 | $48.44 | 171,817 |
| showing 20 of 34 most recent transactions | |||||